260 related articles for article (PubMed ID: 34550859)
1. Nanovaccine: an emerging strategy.
Das A; Ali N
Expert Rev Vaccines; 2021 Oct; 20(10):1273-1290. PubMed ID: 34550859
[TBL] [Abstract][Full Text] [Related]
2. Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance.
Xu Z; Zhou H; Li T; Yi Q; Thakur A; Zhang K; Ma X; Qin JJ; Yan Y
Drug Resist Updat; 2024 Jul; 75():101098. PubMed ID: 38833804
[TBL] [Abstract][Full Text] [Related]
3. Adjuvants in cutaneous vaccination: A comprehensive analysis.
Oladejo M; Tijani AO; Puri A; Chablani L
J Control Release; 2024 May; 369():475-492. PubMed ID: 38569943
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.
Dykman LA
Expert Rev Vaccines; 2020 May; 19(5):465-477. PubMed ID: 32306785
[TBL] [Abstract][Full Text] [Related]
5. Nanocarriers of antigen proteins for vaccine delivery.
Lopes Chaves L; Dourado D; Prunache IB; Manuelle Marques da Silva P; Tacyana Dos Santos Lucena G; Cardoso de Souza Z; Muniz Mendes Freire de Moura P; Nunes Bordallo H; Rocha Formiga F; de Souza Rebouças J
Int J Pharm; 2024 Jun; 659():124162. PubMed ID: 38663646
[TBL] [Abstract][Full Text] [Related]
6. Peptide nanovaccine conjugated
Lv K; Ma S; Liu L; Chen H; Huang Z; Zhu Z; Qi Y; Song W
J Mater Chem B; 2024 Jun; 12(24):5848-5860. PubMed ID: 38775048
[TBL] [Abstract][Full Text] [Related]
7. Multifaceted therapeutic applications of biomimetic nanovaccines.
Chheda D; Shete S; Tanisha T; Devrao Bahadure S; Sampathi S; Junnuthula V; Dyawanapelly S
Drug Discov Today; 2024 Jun; 29(6):103991. PubMed ID: 38663578
[TBL] [Abstract][Full Text] [Related]
8. Harnessing Nanovaccines for Effective Immunization─A Special Concern on COVID-19: Facts, Fidelity, and Future Prospective.
Gholap AD; Gupta J; Kamandar P; Bhowmik DD; Rojekar S; Faiyazuddin M; Hatvate NT; Mohanto S; Ahmed MG; Subramaniyan V; Kumarasamy V
ACS Biomater Sci Eng; 2024 Jan; 10(1):271-297. PubMed ID: 38096426
[TBL] [Abstract][Full Text] [Related]
9. Eliciting B cell immunity against infectious diseases using nanovaccines.
Singh A
Nat Nanotechnol; 2021 Jan; 16(1):16-24. PubMed ID: 33199883
[TBL] [Abstract][Full Text] [Related]
10. Nano-Particulate Platforms for Vaccine Delivery to Enhance Antigen-Specific CD8
Sharma J; Carson CS; Douglas T; Wilson JT; Joyce S
Methods Mol Biol; 2022; 2412():367-398. PubMed ID: 34918256
[TBL] [Abstract][Full Text] [Related]
11. Cancer Vaccines Designed Based the Nanoparticle and Tumor Cells for the Treatment of Tumors: A Perspective.
Wu QJ; Lv WL
IET Nanobiotechnol; 2024; 2024():5593879. PubMed ID: 38863969
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle Vaccines Against Infectious Diseases.
Pati R; Shevtsov M; Sonawane A
Front Immunol; 2018; 9():2224. PubMed ID: 30337923
[TBL] [Abstract][Full Text] [Related]
13. Properties and applications of nanoparticle/microparticle conveyors with adjuvant characteristics suitable for oral vaccination.
Zhang L; Yang W; Hu C; Wang Q; Wu Y
Int J Nanomedicine; 2018; 13():2973-2987. PubMed ID: 29861631
[TBL] [Abstract][Full Text] [Related]
14. Dual-Antigen-Displaying Nanovaccines Elicit Synergistic Immunoactivation for Treating Cancer and Preventing Infectious Complications.
Chen F; Zhang M; Yang F; Wang L; Liu J; Liu J; Pang Y
Small; 2024 Apr; 20(17):e2307748. PubMed ID: 38037689
[TBL] [Abstract][Full Text] [Related]
15. Applications of Nanovaccines for Disease Prevention in Cattle.
Maina TW; Grego EA; Boggiatto PM; Sacco RE; Narasimhan B; McGill JL
Front Bioeng Biotechnol; 2020; 8():608050. PubMed ID: 33363134
[TBL] [Abstract][Full Text] [Related]
16. Clinical perspective on topical vaccination strategies.
G Popova P; Chen SP; Liao S; Sadarangani M; Blakney AK
Adv Drug Deliv Rev; 2024 May; 208():115292. PubMed ID: 38522725
[TBL] [Abstract][Full Text] [Related]
17. Advances and Perspectives in the Use of Carbon Nanotubes in Vaccine Development.
de Carvalho Lima EN; Diaz RS; Justo JF; Castilho Piqueira JR
Int J Nanomedicine; 2021; 16():5411-5435. PubMed ID: 34408416
[TBL] [Abstract][Full Text] [Related]
18. Cancer Nanovaccines: Nanomaterials and Clinical Perspectives.
Desai N; Chavda V; Singh TRR; Thorat ND; Vora LK
Small; 2024 May; ():e2401631. PubMed ID: 38693099
[TBL] [Abstract][Full Text] [Related]
19. A Versatile Nanovaccine Enhancement Strategy Based on Suction-Inspired Physical Therapy.
Wu J; Feng Y; Guo X; Meng M; Li H; Fang H; Li Z; Lin L; Guo Z; Chen J; Tian H; Chen X
ACS Nano; 2024 Feb; 18(6):4957-4971. PubMed ID: 38288709
[TBL] [Abstract][Full Text] [Related]
20. Unlocking the power of nanomedicine: Cell membrane-derived biomimetic cancer nanovaccines for cancer treatment.
Zhao G; Wang S; Nie G; Li N
Med; 2024 Mar; ():. PubMed ID: 38582088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
